Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)

NCT04609098 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT04609098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04609098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2020
Completion date
December 23, 2020
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, falciparum